Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study

By Grimbizis G   Tsalikis T   Tzioufa V   Kasapis M   Mantalenakis S  

Human Reproduction, Vol. 14, Iss. 2, 1999-02 ,pp. : 479-484

Oxford University Press

Access to resources Recommend Favorite

Children. Long-term follow-up of children born after inadvertent administration of a gonadotrophin-releasing hormone agonist in early pregnancy

By Lahat E.  

Human Reproduction, Vol. 14, Iss. 10, 1999-10 ,pp. : 2656-2660

Oxford University Press

Access to resources Recommend Favorite

Up-regulation of apoptosis by gonadotrophin-releasing hormone agonist in cultures of endometrial cells from women with symptomatic myomas

By Kang Jia-Li   Wang Dong-Yu   Wang Xiao-Xia   Yu Jia  

Human Reproduction, Vol. 25, Iss. 9, 2010-09 ,pp. : 2270-2275

Oxford University Press

Access to resources Recommend Favorite

Induction of the endogenous gonadotrophin surge for oocyte maturation with intra-nasal gonadotrophin-releasing hormone analogue (buserelin): effective minimal dose

By Buckett WM  

Human Reproduction, Vol. 13, Iss. 4, 1998-04 ,pp. : 811-814

Oxford University Press

Access to resources Recommend Favorite

Health-related quality of life following surgical menopause and following gonadotrophin-releasing hormone analogue-induced pseudomenopause

By Bhattacharya Sudhindra Mohan  

Gynecological Endocrinology, Vol. 25, Iss. 9, 2009-09 ,pp. : 621-623

Informa Healthcare

Access to resources Recommend Favorite